Genetics and therapy for pediatric eye diseases

EBioMedicine. 2021 May:67:103360. doi: 10.1016/j.ebiom.2021.103360. Epub 2021 May 8.

Abstract

Ocular morphogenesis in vertebrates is a highly organized process, orchestrated largely by intrinsic genetic programs that exhibit stringent spatiotemporal control. Alternations in these genetic instructions can lead to hereditary or nonhereditary congenital disorders, a major cause of childhood visual impairment, and contribute to common late-onset blinding diseases. Currently, limited treatment options exist for clinical phenotypes involving eye development. This review summarizes recent advances in our understanding of early-onset ocular disorders and highlights genetic complexities in development and diseases, specifically focusing on coloboma, congenital glaucoma and Leber congenital amaurosis. We also discuss innovative paradigms for potential therapeutic modalities.

Keywords: Congenital disorders; Eye organogenesis; Ocular diseases; Retinal development; Therapy; Vision impairment.

Publication types

  • Review

MeSH terms

  • Child
  • Eye / embryology
  • Eye / metabolism
  • Eye Diseases, Hereditary / genetics*
  • Eye Diseases, Hereditary / pathology
  • Eye Diseases, Hereditary / therapy
  • Genetic Therapy / methods
  • Humans
  • Molecular Targeted Therapy / methods
  • Stem Cell Transplantation / methods